Display Settings:

Format

Send to:

Choose Destination

    Br J Ophthalmol. 1997 Jun;81(6):443-7.

    Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic.

    Schwartz EC, Huss R, Hopkins A, Dadjim B, Madjitoloum P, Hénault C, Klauss V.

    University Eye Clinic LMU, Munich, Germany.

    AIMS: A population based survey of blindness and visual impairment was conducted in the district of Bossangoa, Central African Republic. METHODS: A total of 48 communities were randomly selected, and 6086 people examined. RESULTS: The prevalence of blindness (visual acuity in the better eye less than 3/60) was 2.2%, and visual impairment 3.0% (6/24 to 3/60 in the better eye). The major causes of blindness were onchocerciasis (73.1%), cataract (16.4%), trachoma (4.5%), and glaucoma (2.2%). CONCLUSION: Around 95.5% of all blindness could potentially have been prevented or treated. Ivermectin mass distribution is hoped to prevent 50% of all forms of visual loss in the future.

    PMID: 9274406 [PubMed - indexed for MEDLINE]

    PMCID: 1722227

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Ivermectin (Stromectol®)

      Ivermectin is used to treat strongyloidiasis (threadworm; infection with a type of roundworm that enters the body through the skin, moves through the airways and lives in the intestines). Ivermectin is also used to contr...